CMS’ Phase 1 Deadline for Vaccine Mandate to Take Effect for Certain States Tomorrow

Butler Snow LLP
Contact

Butler Snow LLP

Following the Supreme Court’s decision in Biden v. Missouri, CMS will require several states to be compliant with the “Phase 1” requirements of its Interim Final Rule (“IFC”) as of January 27, 2022. These states include California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, Tennessee, Vermont, Virginia, Washington, and Wisconsin. As elaborated in our prior guidance following the Supreme Court’s ruling, Phase 1 requires that the staff of healthcare providers subject to the IFC must have received, at a minimum, their first dose of a primary series or a single dose COVID-19 vaccine or been granted a lawful exemption prior to providing any care, treatment, or other services for the facility and/or its patients. Providers must also have developed and implemented appropriate policies and procedures to ensure staff compliance.

Providers in remaining states have until February 14, 2022 to implement Phase 1 requirements, excepting Texas healthcare providers, who have until February 22, 2022. Butler Snow attorneys stand ready to assist healthcare providers in implementing policies and procedures to ensure compliance of their programs with the IFC’s requirements.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Butler Snow LLP | Attorney Advertising

Written by:

Butler Snow LLP
Contact
more
less

Butler Snow LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.